Projets financés
Diagnostic et traitement universels de virus hautement pathogènes – VIGOUROUS
Our consortium addresses the threat posed by hemorrhagic fever viruses (HFV) classified by the US Centers for Disease Control and Prevention (CDC) as Category A and C high-priority agents including Ebola (EBOV), Marburg (MARV), Lassa (LASV), Rift Valley Fever (RVFV), Crimean-Congo Hemorrhagic Fever